Viruses as anticancer drugs
- 1 July 2007
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 28 (7), 326-333
- https://doi.org/10.1016/j.tips.2007.05.005
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Virus evolutionCurrent Opinion in Virology, 2011
- M-T5, the Ankyrin Repeat, Host Range Protein of Myxoma Virus, Activates Akt and Can Be Functionally Replaced by Cellular PIKE-AJournal of Virology, 2007
- Infected Cell Carriers: A New Strategy for Systemic Delivery of Oncolytic Measles Viruses in Cancer VirotherapyMolecular Therapy, 2007
- Phase I, Open-Label, Dose-Escalating Study of a Genetically Engineered Herpes Simplex Virus, NV1020, in Subjects with Metastatic Colorectal Carcinoma to the LiverHuman Gene Therapy, 2006
- The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitroBritish Journal of Cancer, 2006
- Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responsesProceedings of the National Academy of Sciences, 2006
- VSV-tumor selective replication and protein translationOncogene, 2005
- Adaptability costs in immune escape variants of vesicular stomatitis virusVirus Research, 2005
- Criteria for the Appropriate Drug Utilisation of ImmunoglobulinPharmacoEconomics, 1996
- Replicating vectors for gene therapy of cancer: risks, limitations and prospectsEuropean Journal Of Cancer, 1994